Search results
‘The Sympathizer’s’ 27 Emmy Submissions: Director Park Chan-wook’s Episode Pick, Robert Downey Jr.,...
Variety via Yahoo News· 13 hours agoThe satirical spy-thriller “The Sympathizer” hopes to make a mark at the Primetime Emmys this year,...
Cannes Hot List
Los Angeles Magazine· 19 hours agoAs the Cannes Film Festival kicks off with a star-studded lineup, the real intrigue lies beyond the red carpet in the bustling Cannes market, where the...
Ingredion shares get a price target boost to $126 By Investing.com
Investing.com· 7 days agoOn Wednesday, Oppenheimer adjusted its price target on shares of Ingredion (NYSE: NYSE:INGR), a...
RLJ (RLJ Lodging Trust) may reap gains as insiders became active recently – Knox Daily
Knox Daily· 1 day agoA number of analysts have revised their coverage, including Oppenheimer’s analysts, who increased its forecast for the stock in late November from “a Perform” to “an Outperform ...
Brainsway shares target raised by Oppenheimer citing strong sales By Investing.com
Investing.com· 6 days agoThursday, May 9, 2024, saw Brainsway (NASDAQ:BWAY) shares receive a boost to its price target, with ...
Colonial diamond empire De Beers to be sold as Anglo American fights off takeover
Daily Telegraph· 14 hours agoIn 2020, a Rhodes bust on a monument near Table Mountain in Cape Town was decapitated by protestors....
Bradley Cooper may win an Emmy for his 2-minute cameo on ‘Abbott Elementary’
Philly.com· 14 hours agoBradley Cooper doesn’t have an Oscar yet, but the actor is now eyeing an Emmy for his...
Colonial diamond empire De Beers to be sold as Anglo American fights off takeover
The Telegraph via Yahoo Finance· 14 hours agoDe Beers has sought to distance itself from its founder and history in modern times, saying “he does...
MTV Movie & TV Awards won’t happen this year, returns in 2025 with 'reimagined format'
Entertainment Weekly via Yahoo News· 1 day agoThe network offered no official reason for the ceremony’s pause. That unfortunately means that...
CRISPR Therapeutics (NASDAQ:CRSP) Stock Price Down 2.1% After Analyst Downgrade
ETF DAILY NEWS· 4 days agoCRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) shares dropped 2.1% during trading on Friday after Oppenheimer lowered their price target on the stock from $102.00 ...